22.8'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
1E9'CL, ANTI-(NANP) 3 DODECAPEPTIDE
G5 BB 2.2 (AB1), ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
23-52D4, ANTI-ARS
23-4B1, ANTI-ARS
2E7'CL, ANTI-(NANP) 3 DODECAPEPTIDE
G8 AD 3.8, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
C55-8D10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
C95-5A1'CL, ANTI-(TYR,GLU)-ALA-LYS
C80-4E12'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
A.22'CL, ANTI-ARS
C95-4F10'CL, ANTI-(TYR,GLU)-ALA-LYS
ANTI-TGAL 17'CL, ANTI-BRANCHED POLY-L-(TYR,GLU)-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
H51.5.2, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C X DBA/2 HYBRIDOMA
F17.170.2, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
S1-1F4'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
PC49'CL, ANTI-PS1CT3
PC287'CL, ANTI-PSICT3
C16-11D11'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
2A10'CL, ANTI-(NANP) 3 DODECAPEPTIDE
14-2D8, ANTI-ARS
PC43'CL, ANTI-PS1CT3
PC281'CL, ANTI-PSICT3
C80-3E12'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
C94-4B11'CL, ANTI-(TYR,GLU)-ALA-LYS
S8'CL, ANTI-ARS
C23B-10C10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
24-5E1, ANTI-ARS
MS1-1E10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
14-16H2, ANTI-ARS
14-3E12, ANTI-ARS
F17.59.2'CL, ANTI-GLUTAMYLALANYLTYROSYL POLYPEPTIDE HYBRIDOMA
C96-6D7'CL, ANTI-(TYR,GLU)-ALA-LYS
C55-7E3'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
23-54H8, ANTI-ARS
mAb A''CL, ANTI-CYCLOSPORINE
624'CL, ANTI-MEP-1 17-31 PEPTIDE
mAb D'CL, ANTI-CYCLOSPORINE
BPPII-5.1'CL, ANTI-BOVINE PANCREATIC POLYPEPTIDE
TE-32'CL, ANTI-CHOLERA TOXIN PEPTIDE 3
609'CL, ANTI-MEP-1 17-31 PEPTIDE
604'CL, ANTI-MEP-1 17-31 PEPTIDE
NPYII-1.2'CL, ANTI-NEUROPEPTIDE Y
mAb E''CL, ANTI-CYCLOSPORINE
ANTI-ID mAb 114'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-CYCLOSPORINE MAB R45-45-11
mAb C'CL, ANTI-CYCLOSPORINE
BPPI-6.4'CL, ANTI-BOVINE PANCREATIC POLYPEPTIDE
605'CL, ANTI-MEP-1 17-31 PEPTIDE
626'CL, ANTI-MEP-1 17-31 PEPTIDE
mAb D''CL, ANTI-CYCLOSPORINE
mAb B'CL, ANTI-CYCLOSPORINE
mAb G'CL, ANTI-CYCLOSPORINE
NPYII-287.3'CL, ANTI-NEUROPEPTIDE Y
mAb C''CL, ANTI-CYCLOSPORINE
627'CL, ANTI-MEP-1 17-31 PEPTIDE
mAb A'CL, ANTI-CYCLOSPORINE
mAb F'CL, ANTI-CYCLOSPORINE
TE-34'CL, ANTI-CHOLERA TOXIN PEPTIDE 3
17/9'CL, ANTI-INFLUENZA HEMAGGLUTININ PEPTIDE 98-110, YPYDVPDYASLRS
NPYI-46.1'CL, ANTI-NEUROPEPTIDE Y
B13I2'CL, ANTI-PEPTIDE 69-87 OF MYOHEMERYTHRIN.
26/9'CL, ANTI-INFLUENZA HEMAGGLUTININ PEPTIDE 98-110, YPYDVPDYASLRS
mAb B''CL, ANTI-CYCLOSPORINE
628'CL, ANTI-MEP-1 17-31 PEPTIDE
623'CL, ANTI-MEP-1 17-31 PEPTIDE
mAb E'CL, ANTI-CYCLOSPORINE
MCG, ANTI-EPSILON-DNP-LYS, EPSILON-DNP-AMINOCAPROATE, DNP-LEU, TRIACETIN, SODIUM MERTHIOLATE, METHADONE, 1,10-PHENANTHROLINE, CAFFEINE, THEOPHYLLINE, DI-DNP-LYS, DNP-TRP, DNP-PHE, DI-DNP-TYR, COLCHICINE, P-NITROANILINE, P-NITROPHENYLPHOSPHORYL CHOLINE, 5-ACETYLURACIL, MENADIONE, MEPERIDINE, TRIBUTYRIN, OMEGA-BROMOHEPTANOAT
NPYII-14.1'CL, ANTI-NEUROPEPTIDE Y
NPYII-269.3'CL, ANTI-NEUROPEPTIDE Y
TE-33'CL, ANTI-CHOLERA TOXIN PEPTIDE 3
603'CL, ANTI-MEP-1 17-31 PEPTIDE
611'CL, ANTI-MEP-1 17-31 PEPTIDE

1E9''CL, ANTI-(NANP)3 DODECAPEPTIDE
ANTI-TGAL 6'CL, ANTI-BRANCHED POLY-L-(TYR,GLU)-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
C55-7F10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
C20-7D6'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
6-3B3, ANTI-ARS
C52-6D9'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
PC47'CL, ANTI-PS1CT3
2C11'CL, ANTI-(NANP) 3 DODECAPEPTIDE
G2'CL, ANTI-ARS
J7-11H3'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
14-32A3, ANTI-ARS
C16-15F6'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
F.12'CL, ANTI-ARS
6-2F11, ANTI-ARS
20.11'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
22.176'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
14-43E4, ANTI-ARS
PRECURSOR'CL, ANTI-PSICT3
C97-2B6'CL, ANTI-(TYR,GLU)-ALA-LYS
A.18'CL, ANTI-ARS
F17.170.2'CL, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C X DBA/2 HYBRIDOMA
S1-1H5'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
GAT50'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
PC289'CL, ANTI-PSICT3
11-9A12, ANTI-ARS
C6-7F12'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
S17'CL, ANTI-ARS
S25'CL, ANTI-ARS
C52-4H3'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
PC41'CL, ANTI-PS1CT3
A.21'CL, ANTI-ARS
PC2812'CL, ANTI-PSICT3
PC284'CL, ANTI-PSICT3
C94-10B9'CL, ANTI-(TYR,GLU)-ALA-LYS
14-37A1, ANTI-ARS
S32'CL, ANTI-ARS
H56.406.48, ANTI-POLY(GLU60,ALA30,TYR10) DBA/2 HYBRIDOMA
PC45'CL, ANTI-PS1CT3
24A5'CL, ANTI-PH(D)
D.3'CL, ANTI-ARS
14-30E4, ANTI-ARS
14-9F3, ANTI-ARS
G3'CL, ANTI-ARS
PC283'CL, ANTI-PSICT3
11-1G2, ANTI-ARS
14-13D1, ANTI-ARS
G7 AB 2.9, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
ANTI-TGAL 14'CL, ANTI-BRANCHED POLY-L-(TYR,GLU)-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
C5-7B12'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
C52-3G1'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
11-14F5, ANTI-ARS
G8 CA 1.7, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
PC42'CL, ANTI-PS1CT3
C94-5B11'CL, ANTI-(TYR,GLU)-ALA-LYS
36-65'CL, ANTI-ARS
24-2G3, ANTI-ARS
S18'CL, ANTI-ARS
G1'CL, ANTI-ARS
14-41A10, ANTI-ARS
7-F1, ANTI-ARS
14-29A1, ANTI-ARS
14-36E1, ANTI-ARS
G5 BB 2.2, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
64-16G1, ANTI-ARS
S21'CL, ANTI-ARS
S3'CL, ANTI-ARS
3D6'CL, ANTI-(NANP) 3 DODECAPEPTIDE
